Yongke Zhang
Chief Scientific Officer IASO Biotherapeutics
Dr. Yongke Zhang serves as the Chief Scientific Officer at IASO Bio with over 26 years of experience in the industry. His career includes roles at Merck Research Labs, AbbVie, Epitomics, Apexigen, AbCyte Therapeutics, and OBiO Tech in the USA, leading therapeutic antibody, CAR-T cell therapies, preclinical development, and clinical research. He holds a doctor’s degree in Internal Medicine, Clinical Medicine from the Health Science Center of Peking University and a doctor’s degree in Cell and Molecular Biology from the University of Tokyo.
Seminars
Wednesday 16th September 2026
Building In Vivo Clinical Success Leveraging the IIT Pathway to Accelerate Global Clinical Development
3:30 pm
- Expand clinical momentum by leveraging the IIT pathway to generate early human data across BCMA in vivo CAR and CD19 CAR-T
- Utilizing clinical insights to inform development strategy
- Sharing practical learnings from IND and IIT discussions to navigate regulatory engagement effectively
